From prediction to partnership: positioning machine learning as a decision-support tool for nursing risk assessment in postoperative infection prevention

Dear Editor, We read with great interest the recent article by Zhang et al, “Construct validation of machine learning models for predicting surgical site infection risk following ankle fracture surgery”[1]. The authors are to be commended for their rigorous development and validation of a high-performing Gradient Boosting Machine model, which adds to the growing evidence of machine learning’s (ML) superior statistical accuracy in surgical site infection (SSI) prediction. However, a systematic evaluation of the field reveals a common gap: many models excel in internal validation yet lack assessment of their real-world clinical utility and integration[2]. I wish to argue that for ML to realize its potential in preventing SSIs, its role must be redefined from a standalone prediction engine to an integrated decision-support tool that empowers, rather than bypasses, frontline nursing assessment and intervention. A primary limitation of the current paradigm is the constrained evaluation of clinical utility. While Zhang et al expertly validated their model’s discrimination and calibration, the crucial test of how such a tool integrates into and alters real-world nursing workflows remains unaddressed[1]. True utility is measured not only by the area under the curve but by whether it improves processes and outcomes. For instance, does it reduce the cognitive load of sifting through records, or does it create additional alert fatigue? A forward-looking study demonstrate this principle by not only developing a multimodal SSI predictor but also simulating its integration to show a potential 80% reduction in clinician chart review time – a direct metric of workflow enhancement[3]. This is the kind of evidence needed to move from prediction to partnership. Furthermore, to be a trustworthy partner in care, these tools must be robust and interpretable in the face of clinical realities. The “highly imbalanced data” ubiquitous in SSI prediction pose a significant challenge to model reliability[4]. Nurses rely on tools that are sensitive to true risk; a model biased by class imbalance may fail those most vulnerable. Simultaneously, the pursuit of complex models may not always be warranted, as evidenced by studies where simpler, interpretable models like logistic regression performed comparably or better in external validation[5]. For nursing decision-support, explainability is non-negotiable. A risk score is far less actionable than knowing that score is driven primarily by a patient’s hypoalbuminemia and poor glycemic control, enabling targeted, preemptive interventions. The ultimate value of ML may lie not in replacing but in augmenting the clinical timeline with dynamic insights. The concept of utilizing dynamic health data for continuous prognosis, though proposed earlier[6], finds modern application in models that update risk predictions based on postoperative data[2]. This shift from a static preoperative score to a dynamic “vital sign” for infection risk could transform nursing surveillance, allowing for resource prioritization that adapts to the patient’s evolving condition. Therefore, the most promising path forward is not human-versus-AI competition, but collaboration. Future research should pivot toward “nurse-in-the-loop” study designs[7]. The goal should be to evaluate whether an ML tool, providing interpretable risk stratification, enhances a nurse’s clinical judgment and leads to earlier prevention. This aligns with the vision of AI as part of a broader intelligent infection control ecosystem, supporting tasks from individual risk alerting to resource optimization across hospital units[7]. In conclusion, the excellent work by Zhang et al provides a robust predictive model[1]. The next essential step is to embed such models into the clinical fabric. We urge the research community to shift focus from solely optimizing algorithms to designing ML systems as collaborative decision-support tools. By doing so, we can ensure these technological advances translate into enhanced nursing vigilance, streamlined workflows, and, ultimately, safer patient care.

Authors

Institutions

Publication Details

Journal
International Journal of Surgery
Published
2026-03-17
DOI
https://doi.org/10.1097/js9.0000000000005065
Primary Topic
Surgical site infection prevention
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From prediction to partnership: positioning machine learning as a decision-support tool for nursing risk assessment in postoperative infection prevention

J. Cheng-Chung Wei, ShaoHui Geng, Anqi Liu
International Journal of Surgery
Surgical site infection prevention
article

From prediction to partnership: positioning machine learning as a decision-support tool for nursing risk assessment in postoperative infection prevention

J. Cheng-Chung Wei, ShaoHui Geng, Anqi Liu
article en

Abstract

Dear Editor, We read with great interest the recent article by Zhang et al, “Construct validation of machine learning models for predicting surgical site infection risk following ankle fracture surgery”[1]. The authors are to be commended for their rigorous development and validation of a high-performing Gradient Boosting Machine model, which adds to the growing evidence of machine learning’s (ML) superior statistical accuracy in surgical site infection (SSI) prediction. However, a systematic evaluation of the field reveals a common gap: many models excel in internal validation yet lack assessment of their real-world clinical utility and integration[2]. I wish to argue that for ML to realize its potential in preventing SSIs, its role must be redefined from a standalone prediction engine to an integrated decision-support tool that empowers, rather than bypasses, frontline nursing assessment and intervention. A primary limitation of the current paradigm is the constrained evaluation of clinical utility. While Zhang et al expertly validated their model’s discrimination and calibration, the crucial test of how such a tool integrates into and alters real-world nursing workflows remains unaddressed[1]. True utility is measured not only by the area under the curve but by whether it improves processes and outcomes. For instance, does it reduce the cognitive load of sifting through records, or does it create additional alert fatigue? A forward-looking study demonstrate this principle by not only developing a multimodal SSI predictor but also simulating its integration to show a potential 80% reduction in clinician chart review time – a direct metric of workflow enhancement[3]. This is the kind of evidence needed to move from prediction to partnership. Furthermore, to be a trustworthy partner in care, these tools must be robust and interpretable in the face of clinical realities. The “highly imbalanced data” ubiquitous in SSI prediction pose a significant challenge to model reliability[4]. Nurses rely on tools that are sensitive to true risk; a model biased by class imbalance may fail those most vulnerable. Simultaneously, the pursuit of complex models may not always be warranted, as evidenced by studies where simpler, interpretable models like logistic regression performed comparably or better in external validation[5]. For nursing decision-support, explainability is non-negotiable. A risk score is far less actionable than knowing that score is driven primarily by a patient’s hypoalbuminemia and poor glycemic control, enabling targeted, preemptive interventions. The ultimate value of ML may lie not in replacing but in augmenting the clinical timeline with dynamic insights. The concept of utilizing dynamic health data for continuous prognosis, though proposed earlier[6], finds modern application in models that update risk predictions based on postoperative data[2]. This shift from a static preoperative score to a dynamic “vital sign” for infection risk could transform nursing surveillance, allowing for resource prioritization that adapts to the patient’s evolving condition. Therefore, the most promising path forward is not human-versus-AI competition, but collaboration. Future research should pivot toward “nurse-in-the-loop” study designs[7]. The goal should be to evaluate whether an ML tool, providing interpretable risk stratification, enhances a nurse’s clinical judgment and leads to earlier prevention. This aligns with the vision of AI as part of a broader intelligent infection control ecosystem, supporting tasks from individual risk alerting to resource optimization across hospital units[7]. In conclusion, the excellent work by Zhang et al provides a robust predictive model[1]. The next essential step is to embed such models into the clinical fabric. We urge the research community to shift focus from solely optimizing algorithms to designing ML systems as collaborative decision-support tools. By doing so, we can ensure these technological advances translate into enhanced nursing vigilance, streamlined workflows, and, ultimately, safer patient care.

International Journal of Surgery
Beijing University of Chinese Medicine (CN), Southern University of Science and Technology (CN), Southern Medical University Shenzhen Hospital (CN), Shenzhen Second People's Hospital (CN)
Openalex Percentile: Top 19%
Surgical site infection prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.